These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 16413071)
1. Mutation of Thr466 in SHP2 abolishes its phosphatase activity, but provides a new substrate-trapping mutant. Merritt R; Hayman MJ; Agazie YM Biochim Biophys Acta; 2006 Jan; 1763(1):45-56. PubMed ID: 16413071 [TBL] [Abstract][Full Text] [Related]
3. Phosphotyrosines 627 and 659 of Gab1 constitute a bisphosphoryl tyrosine-based activation motif (BTAM) conferring binding and activation of SHP2. Cunnick JM; Mei L; Doupnik CA; Wu J J Biol Chem; 2001 Jun; 276(26):24380-7. PubMed ID: 11323411 [TBL] [Abstract][Full Text] [Related]
4. A specific amino acid context in EGFR and HER2 phosphorylation sites enables selective binding to the active site of Src homology phosphatase 2 (SHP2). Hartman Z; Geldenhuys WJ; Agazie YM J Biol Chem; 2020 Mar; 295(11):3563-3575. PubMed ID: 32024694 [TBL] [Abstract][Full Text] [Related]
5. Modulation of alpha-catenin Tyr phosphorylation by SHP2 positively effects cell transformation induced by the constitutively active FGFR3. Burks J; Agazie YM Oncogene; 2006 Nov; 25(54):7166-79. PubMed ID: 16767162 [TBL] [Abstract][Full Text] [Related]
6. Development of an efficient "substrate-trapping" mutant of Src homology phosphotyrosine phosphatase 2 and identification of the epidermal growth factor receptor, Gab1, and three other proteins as target substrates. Agazie YM; Hayman MJ J Biol Chem; 2003 Apr; 278(16):13952-8. PubMed ID: 12582165 [TBL] [Abstract][Full Text] [Related]
7. The tyrosine phosphatase Shp2 interacts with NPM-ALK and regulates anaplastic lymphoma cell growth and migration. Voena C; Conte C; Ambrogio C; Boeri Erba E; Boccalatte F; Mohammed S; Jensen ON; Palestro G; Inghirami G; Chiarle R Cancer Res; 2007 May; 67(9):4278-86. PubMed ID: 17483340 [TBL] [Abstract][Full Text] [Related]
9. Negative regulation of gp130 signalling mediated through tyrosine-757 is not dependent on the recruitment of SHP2. Fairlie WD; De Souza D; Nicola NA; Baca M Biochem J; 2003 Jun; 372(Pt 2):495-502. PubMed ID: 12593670 [TBL] [Abstract][Full Text] [Related]
10. HSP70 binds to SHP2 and has effects on the SHP2-related EGFR/GAB1 signaling pathway. Yoo JC; Hayman MJ Biochem Biophys Res Commun; 2006 Dec; 351(4):979-85. PubMed ID: 17097051 [TBL] [Abstract][Full Text] [Related]
11. A novel role for Gab1 and SHP2 in epidermal growth factor-induced Ras activation. Montagner A; Yart A; Dance M; Perret B; Salles JP; Raynal P J Biol Chem; 2005 Feb; 280(7):5350-60. PubMed ID: 15574420 [TBL] [Abstract][Full Text] [Related]
12. The protein tyrosine phosphatase, Shp2, is required for the complete activation of the RAS/MAPK pathway by brain-derived neurotrophic factor. Easton JB; Royer AR; Middlemas DS J Neurochem; 2006 May; 97(3):834-45. PubMed ID: 16573649 [TBL] [Abstract][Full Text] [Related]
13. The SH2 tyrosine phosphatase shp2 is required for mammalian limb development. Saxton TM; Ciruna BG; Holmyard D; Kulkarni S; Harpal K; Rossant J; Pawson T Nat Genet; 2000 Apr; 24(4):420-3. PubMed ID: 10742110 [TBL] [Abstract][Full Text] [Related]
14. Reduced phosphatase activity of SHP-2 in LEOPARD syndrome: consequences for PI3K binding on Gab1. Hanna N; Montagner A; Lee WH; Miteva M; Vidal M; Vidaud M; Parfait B; Raynal P FEBS Lett; 2006 May; 580(10):2477-82. PubMed ID: 16638574 [TBL] [Abstract][Full Text] [Related]
15. Diverse biochemical properties of Shp2 mutants. Implications for disease phenotypes. Keilhack H; David FS; McGregor M; Cantley LC; Neel BG J Biol Chem; 2005 Sep; 280(35):30984-93. PubMed ID: 15987685 [TBL] [Abstract][Full Text] [Related]
16. Use of Dominant-Negative/Substrate Trapping PTP Mutations to Search for PTP Interactors/Substrates. Radha V Methods Mol Biol; 2016; 1447():243-65. PubMed ID: 27514810 [TBL] [Abstract][Full Text] [Related]
17. The role of Cys12, Cys17 and Arg18 in the catalytic mechanism of low-M(r) cytosolic phosphotyrosine protein phosphatase. Cirri P; Chiarugi P; Camici G; Manao G; Raugei G; Cappugi G; Ramponi G Eur J Biochem; 1993 Jun; 214(3):647-57. PubMed ID: 8319676 [TBL] [Abstract][Full Text] [Related]
18. The tyrosine phosphatase SHP2 modulates MAP kinase p38 and caspase 1 and 3 to foster neuronal survival. Chong ZZ; Lin SH; Kang JQ; Maiese K Cell Mol Neurobiol; 2003 Oct; 23(4-5):561-78. PubMed ID: 14514016 [TBL] [Abstract][Full Text] [Related]
19. Structural and functional effects of disease-causing amino acid substitutions affecting residues Ala72 and Glu76 of the protein tyrosine phosphatase SHP-2. Bocchinfuso G; Stella L; Martinelli S; Flex E; Carta C; Pantaleoni F; Pispisa B; Venanzi M; Tartaglia M; Palleschi A Proteins; 2007 Mar; 66(4):963-74. PubMed ID: 17177198 [TBL] [Abstract][Full Text] [Related]
20. Determination of the catalytic activity of LEOPARD syndrome-associated SHP2 mutants toward parafibromin, a bona fide SHP2 substrate involved in Wnt signaling. Noda S; Takahashi A; Hayashi T; Tanuma S; Hatakeyama M Biochem Biophys Res Commun; 2016 Jan; 469(4):1133-9. PubMed ID: 26742426 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]